DewDiligence Thursday, 06/04/20 11:15:26 PM Re: None Post # of 549 FDA approves MRK’s Recarbrio (a combination of three agents) for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: https://www.prnewswire.com/news-releases/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-301071053.html Recarbrio was previously FDA-approved for patients with complicated urinary tract infections and complicated intra-abdominal infections. “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”